United States

Showing 221-230 of 333 grants

Title	Institution	Researcher	Program	Duration	Total Award Amount
PLGA nanoparticle treatment-induced antigen-specific CD4+ regulatory T cell control of effector CD8+ T cell responses in a model of type 1 diabetes	Northwestern University	Stephen Miller	Cures	01-September-2025 to 31-August-2028	$659,990.00
Engineering hypoimmune cells for Type 1 Diabetes	New York Stem Cell Foundation, Inc.	Daniel Paull	Cures	01-May-2025 to 30-April-2028	$1,498,415.83
GPR75, a novel actor in beta cell regeneration	New York Medical College	Ercument Dirice	Cures	01-April-2022 to 31-March-2026	$750,000.00
Preclinical evaluation of SERCA2 activators for pancreatic beta-cell protection in T1D	Neurodon LLC	Russell Dahl	Cures	01-June-2022 to 31-October-2025	$920,000.00
Transdisciplinary Care for Young Adults with Type 1 Diabetes Transitioning to Adult Healthcare	Nemours Children's Clinic	Jessica Pierce	Improving Lives	01-May-2023 to 30-April-2026	$628,819.87
Anti-Serpin B13 Hu-mAb Lead Candidate Developability Assessment	Mosaic Biosciences, Inc.	Malavi Madireddi	Cures	01-June-2025 to 01-April-2026	$293,674.00
Real time monitoring of a cell therapy product to assess and modify transplant health post-engraftment in patients with type 1 diabetes	Minutia	Katy Digovich	Cures	01-November-2022 to 30-November-2025	$1,198,600.00
Market Analysis of Devices Utilized By Patients With T1D & Eligibility For Future T1D Cell and Gene Therapies	Milliman	Rebecca Smith	Cures	01-January-2025 to 31-October-2025	$380,000.00
Market Analysis of Insulin Products Utilized by Patients With T1D & Pervasiveness of Insulin Caps	Milliman	Rebecca Smith	Transportfolio	01-January-2025 to 01-October-2025	$545,000.00
Multicolor cellular immunoimaging of response to transplanted islet cells	Michigan State University	Bryan Smith	Cures	01-June-2023 to 31-May-2026	$750,000.00